Walking exercise response to bronchodilation in mild COPD: A randomized trial

Respiratory Medicine

Volumn 106, Issue 12, 2012, Pages 1695-1705

  Gagnon, Philippe ^a   Saey, Didier ^a   Provencher, Steeve ^a   Milot, Julie ^a   Bourbeau, Jean ^b   Tan, Wan C ^c   Martel, Simon ^a   Maltais, François ^a  

^a LAVAL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Bronchodilators; Chronic obstructive pulmonary disease; Exercise tolerance; GOLD I; Walking

Indexed keywords

IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE;

ADULT; AGED; ARTICLE; BREATHING PATTERN; BREATHING RATE; BRONCHODILATATION; CARDIOPULMONARY FUNCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ENDURANCE; EXERCISE TOLERANCE; EXHAUSTION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INSPIRATORY CAPACITY; MALE; MUSCLE FATIGUE; NEBULIZATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; TIDAL VOLUME; WALKING;

ADMINISTRATION, INHALATION; AGED; ALBUTEROL; ANALYSIS OF VARIANCE; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; IPRATROPIUM; MALE; OXYGEN CONSUMPTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE; RESPIRATORY FUNCTION TESTS; WALKING;

EID: 84867743197     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2012.08.021     Document Type: Article

References (38)

1. Global strategy for diagnosis, management, and prevention of chronic pulmonary obstructive disease (GOLD) - updated 2011. Available from: http://wwwgoldcopdorg.
2. B.R. Celli, and W. MacNee Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur Respir J 23 2004 932 946
3. D.E. O'Donnell, S. Aaron, J. Bourbeau, P. Hernandez, and D.D. Marciniuk Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update Can Respir J 14 Suppl. B 2007 5B 32B
4. D.E. O'Donnell, P. Laveneziana, J. Ora, K.A. Webb, and Y.M. Lam Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD Thorax 64 2009 216 223
5. D. Ofir, P. Laveneziana, K.A. Webb, Y.M. Lam, and D.E. O'Donnell Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease Am J Respir Crit Care Med 177 2008 622 629
6. N. Raghavan, J.A. Guenette, and D.E. O'Donnell The role of pharmacotherapy in mild to moderate chronic obstructive pulmonary disease Ther Adv Respir Dis 5 2011 245 254
7. G.T. Ferguson Maintenance pharmacotherapy of mild and moderate COPD: what is the evidence? Respir Med 105 2011 1268 1274
8. R. Rodriguez-Roisin, M. Drakulovic, D.A. Rodriguez, J. Roca, and J.A. Barbera Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity J Appl Physiol 106 2009 1902 1908
9. F. Maltais, B. Celli, R. Casaburi, J. Porszasz, and D. Jarreta Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD Repir Med 105 2011 580 587
10. F. Maltais, A. Hamilton, D. Marciniuk, P. Hernandez, and F.C. Sciurba Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD Chest 128 2005 1168 1178
11. D.E. O'Donnell, T. Fluge, F. Gerken, A. Hamilton, and K. Webb Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD Eur Respir J 23 2004 832 840
12. D.E. O'Donnell, F. Sciurba, B. Celli, D.A. Mahler, and K.A. Webb Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD Chest 130 2006 647 656
13. D.E. O'Donnell, N. Voduc, M. Fitzpatrick, and K.A. Webb Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease Eur Respir J 24 2004 86 94
14. V. Pepin, D. Saey, F. Whittom, P. Leblanc, and F. Maltais Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease Am J Respir Crit Care Med 172 2005 1517 1522
15. D. Saey, R. Debigaré, P. Leblanc, M.J. Mador, and C.H. Côté Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 168 2003 425 430
16. F. Pitta, T. Troosters, M.A. Spruit, V.S. Probst, and M. Decramer Characteristics of physical activities in daily life in chronic obstructive pulmonary disease Am J Respir Crit Care Med 171 2005 972 977
17. D.A. Mahler, D.H. Weinberg, C.K. Wells, and A.R. Feinstein The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes Chest 85 1984 751 758
18. C.M. Fletcher, P.C. Elmes, A.S. Fairbairn, and C.H. Wood The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population Br Med J 2 1959 257 266
19. K.F. Schulz, D.G. Altman, and D. Moher CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials Ann Intern Med 152 2010 726 732
20. V. Pepin, J. Brodeur, Y. Lacasse, J. Milot, and P. Leblanc Six-minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary disease Thorax 62 2007 291 298
21. American Thoracic Society Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (ATS) Am J Respir Crit Care Med 152 1995 S77 121
22. P.H. Quanjer, G.J. Tammeling, J.E. Cotes, O.F. Pedersen, and R. Peslin Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European Community for Steel and Coal Eur Respir J Suppl 16 1993 5 40
23. J.L. Hankinson, J.R. Odencrantz, and K.B. Fedan Spirometric reference values from a sample of the general U.S. population Am J Respir Crit Care Med 159 1999 179 187
24. K.F. Rabe, S. Hurd, A. Anzueto, P.J. Barnes, and S.A. Buist Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 2007 532 555
25. B. Gandevia, and P. Hugh-Jones Terminology for measurements of ventilatory capacity; a report to the thoracic society Thorax 12 1957 290 293
26. S.J. Singh, M.D. Morgan, S. Scott, D. Walters, and A.E. Hardman Development of a shuttle walking test of disability in patients with chronic airways obstruction Thorax 47 1992 1019 1024
27. G.A. Borg Psychophysical bases of perceived exertion Med Sci Sports Exerc 14 1982 377 381
28. S.M. Revill, M.D. Morgan, S.J. Singh, J. Williams, and A.E. Hardman The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease Thorax 54 1999 213 222
29. G.H. Guyatt, S.O. Pugsley, M.J. Sullivan, P.J. Thompson, and L. Berman Effect of encouragement on walking test performance Thorax 39 1984 818 822
30. C. Brouillard, V. Pepin, J. Milot, Y. Lacasse, and F. Maltais Endurance shuttle walking test: responsiveness to salmeterol in COPD Eur Respir J 31 2008 579 584
31. P. Gagnon, D. Saey, I. Vivodtzev, L. Laviolette, and V. Mainguy Impact of pre-induced quadriceps fatigue on exercise response in chronic obstructive pulmonary disease and healthy subjects J Appl Physiol 107 2009 832 840
32. V. Pepin, L. Laviolette, C. Brouillard, L. Sewell, and S.J. Singh Significance of changes in endurance shuttle walking performance Thorax 66 2011 115 120
33. R. Pellegrino, G. Viegi, V. Brusasco, R.O. Crapo, and F. Burgos Interpretative strategies for lung function tests Eur Respir J 26 2005 948 968
34. W.D. Man, M.G. Soliman, J. Gearing, S.G. Radford, and G.F. Rafferty Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease Am J Respir Crit Care Med 168 2003 562 567
35. D.E. O'Donnell, L. Forkert, and K.A. Webb Evaluation of bronchodilator responses in patients with "irreversible" emphysema Eur Respir J 18 2001 914 920
36. D.E. O'Donnell, A.L. Hamilton, and K.A. Webb Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD J Appl Physiol 101 2006 1025 1035
37. D.E. O'Donnell, M. Lam, and K.A. Webb Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease Am J Respir Crit Care Med 160 1999 542 549
38. M.R. Miller, P.H. Quanjer, M.P. Swanney, G. Ruppel, and P.L. Enright Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients Chest 139 2011 52 59